Our results show the essential role of STAT3 in the type I/II IFN-mediated upregulation of the anti-apoptotic protein Mcl-1, and this might have implications in the context of the therapeutic potential of STAT3 and Mcl-1 inhibitors in CLL. Here, MCL1 is linked to B-cell chronic lymphocytic leukemia.